相关实验视频

Updated: May 6, 2026

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

背景在PURPOSE 1和2 PrEP试验中的HIV发病率

Jean-Jacques Parienti^1,2

¹Department of Biostatistics and Clinical Research, Caen University Hospital, Caen, France.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

|August 14, 2025

概括

背景在PURPOSE试验中,艾滋病毒发病率与口服PrEP使用者与低坚持率密切相关. 这一发现支持在预防试验中使用背景发病率作为比较值,避免安慰剂手臂.

科学领域:

公共卫生公共卫生
传染病流行病学传染病流行病学
临床试验临床试验

背景情况:

暴露前预防 (PrEP) 是一种关键的艾滋病毒预防策略.
评估新的艾滋病毒预防方法需要强大的比较器.
预防试验中的安慰剂武器引发了伦理方面的担忧.

研究的目的:

为了评估背景艾滋病毒发病率 (bHIV) 与口服PrEP使用的关系.
为了确定bHIV作为HIV预防试验中的比较剂的适用性.
支持对新型艾滋病毒预防策略的道德和有效评估.

主要方法:

来自PURPOSE 1和2临床试验的HIV发病率数据的分析.
较低坚持性口服PrEP使用者之间的HIV发病率与背景发病率的比较.
作为保守的比较对象的bHIV的统计评估.

主要成果:

在PURPOSE 1和2中,口服PrEP使用者的艾滋病毒发病率与HIV.bHIV.bHIV.bHIV.bHIV.bHIV.bHIV.bHIV.bHIV.bHIV.bHIV.bHIV.bHIV.bHIV.bHIV.bHIV.bHIV.bHIV.bHIV.
这表明bHIV是一个保守和适当的比较器.
这些发现验证了bHIV的使用,而不是安慰剂手臂.

结论:

背景艾滋病毒发病率在PrEP试验中作为一个有效和保守的比较值.
利用bHIV可以为新的艾滋病毒预防策略进行更道德和更有效的临床试验.
这种方法简化了评估过程,可能加快有效干预措施的可用性.

关键词:

背景艾滋病毒发病率设计设计设计设计设计设计.这就是为什么PrEP是PrEP.这是一个反事实性的反事实.

更多相关视频

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment

Published on: June 23, 2019

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

相关概念视频

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...